Gaboxadol

N/A

Report date: 2025/11/02 20:00:06
NME

Base Information

Drug NameGaboxadol
Drug Alias NameTHIP加波沙朵加波沙多GaboxadoleLu-02-030 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsDepressive Disorder, MajorSleep Initiation and Maintenance DisordersFragile X Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenNetherlands +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOvid Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAngelini PharmaHealx Ltd
Inactive CompaniesOvid Therapeutics IncH. Lundbeck A/S
Active IndicationsFragile X Syndrome
Inactive IndicationsDepressive Disorder, MajorSleep Initiation and Maintenance DisordersAngelman Syndrome

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG